XLO Institutional Ownership
Top institutional (13F) holders of XLO and 5%+ (13D/G) positions, sourced from SEC EDGAR.
Institutional owners
13
Institutional value
$4.16M
Top holder
Vanguard Capital Management
Couldn’t find the data you were looking for?
We haven’t added Xilio Therapeutics, Inc.’s filings yet. We add companies and filings all the time.
Track XLO and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Top holders
| Holder | Filed | Value |
|---|---|---|
| Vanguard Capital Managementinvestment advisor | Aug 13, 2026 | $1.71M |
| RENAISSANCE TECHNOLOGIES LLCinvestment advisor | Aug 13, 2026 | $614.6K |
| MORGAN STANLEYholding company | Aug 13, 2026 | $545.6K |
| GEODE CAPITAL MANAGEMENT, LLCinvestment advisor | Nov 6, 2026 | $375.1K |
| FMR LLCinvestment advisor | May 15, 2026 | $307.5K |
| CITADEL ADVISORS LLCinvestment advisor | Sep 1, 2026 | $248.6K |
| TWO SIGMA INVESTMENTS, LPinvestment advisor | Aug 14, 2026 | $139.3K |
| STATE STREET CORPORATIONholding company | Sep 22, 2026 | $127.5K |
| BlackRock, Inc.holding company | Aug 7, 2026 | $83.9K |
| JPMORGAN CHASE & COholding company | May 13, 2026 | $2K |
| ROYAL BANK OF CANADAholding company | May 15, 2026 | $1K |
| UBS Group AGbank | Aug 13, 2026 | $134 |
| CITIGROUP INCinvestment advisor | Nov 4, 2026 | $9 |
5%+ holders
Current stakes of 5% or more from Schedule 13D and 13G filings. A joint filing shows once, under its lead filer.
No current 5%+ holders of XLO on file.
Never miss a XLO filing.
Get an email when XLO files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR Schedule 13D / 13G and 13F filings.